Table 1 The left part of the table describes exposure details of animals irradiated following different partial body irradiation (PBI) exposure pattern or total body irradiation (TBI) exposures with different doses resulting in each animal in either 2.5 Gy or 5 Gy whole body equivalent doses.

From: Persistent mRNA and miRNA expression changes in irradiated baboons

ID #

Exposure (Co-60)

days after exposure

stage I screening, samples from days…

stage II independent validation, samples from days…

radiation dose (Gy, free in air)/ body area (%)

PBI

TBI

1

5 PBI 50%

left-hemibody exposed

 

0

0

 
 

7

 

7

 

28

 

28

 

75–106

 

75–106

2

5 PBI 50%

left-hemibody exposed

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

3

15 PBI 30%

head + arms exposed

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

4

15 PBI 30%

head + arms exposed

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

5

6.25 PBI 80%

2 legs shielded

 

0

 

0

 

7

 

7

 

28

 

28

 

75–106

 

75–106

6

6.25 PBI 80%

2 legs shielded

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

7

10 PBI 50%

left-hemibody exposed

 

0

 

0

 

7

 

7

 

28

 

28

 

75–106

 

75–106

8

10 PBI 50%

left-hemibody exposed

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

9

5.55 PBI 90%

1 leg shielded

 

0

 

0

 

7

7

 
 

28

28

 
 

75–106

75–106

 

10

5.55 PBI 90%

1 leg shielded

 

0

 

0

 

7

 

7

 

28

 

28

 

75–106

 

75–106

11

6.25 PBI 80%

2 legs shielded

 

0

0

 
 

7

 

7

 

28

 

28

 

75–106

 

75–106

12

6.25 PBI 80%

2 legs shielded

 

0

 

0

 

7

 

7

 

28

 

28

 

75–106

 

75–106

13

2.5 TBI 100%

 

TBI

0

0

 

7

 

7

28

 

28

75–106

 

75–106

14

2.5 TBI 100%

 

TBI

0

 

0

7

7

 

28

28

 

75–106

75–106

 

15

5 TBI 100%

 

TBI

0

0

 

7

 

7

28

 

28

75–106

 

75–106

16

5 TBI 100%

 

TBI

0

0

 

7

 

7

28

 

28

75–106

 

75–106

17

7.5 / 2.5 TBI 100%

 

TBI

0

 

0

7

 

7

28

 

28

75–106

 

75–106

  1. The right part of the table depicts the assignment of RNA samples to the screening (stage I) or the independent validation (stage II) phase of the study.